WallStreetZenWallStreetZen

NASDAQ: HSDT
Helius Medical Technologies Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Be the first to know when Wall Street analysts revise their HSDT stock forecasts and price targets.

Forecast return on equity

Is HSDT forecast to generate an efficient return?

Insufficient data to display

Forecast return on assets

Is HSDT forecast to generate an efficient return on assets?

Company
-570.94%
Industry
10.09%
HSDT is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

HSDT earnings per share forecast

What is HSDT's earnings per share in the next 2 years based on estimates from 3 analysts?

Avg 1 year Forecast
-$258.57
Avg 2 year Forecast
-$65.79

HSDT revenue forecast

What is HSDT's revenue in the next 2 years based on estimates from 3 analysts?

Avg 1 year Forecast
$381.5k-59.46%
Avg 2 year Forecast
$668.1k-29%
HSDT's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

HSDT revenue growth forecast

How is HSDT forecast to perform vs Medical Devices companies and vs the US market?

Company
-59.46%
Industry
4%
Market
1,432.68%
HSDT's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
HSDT's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

HSDT vs Medical Device Stocks

TickerPricePrice TargetUp/downsideConsensus
HSDT$2.98N/AN/A
APYX$3.49$7.00+100.57%Strong Buy
ANIK$9.57$16.00+67.19%Buy
XTNT$0.77$1.50+94.81%Strong Buy
LUNG$2.60$5.70+119.23%Buy
View Top Medical Device Stocks

Helius Medical Technologies Stock Forecast FAQ

What is HSDT's earnings growth forecast for 2025-2026?

(NASDAQ: HSDT) Helius Medical Technologies's forecast annual earnings growth rate of N/A is not forecast to beat the US Medical Devices industry's average forecast earnings growth rate of 27.26%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 2,932.28%.

Helius Medical Technologies's earnings in 2025 is -$370,367,000.On average, 3 Wall Street analysts forecast HSDT's earnings for 2025 to be -$10,679,302,998, with the lowest HSDT earnings forecast at -$10,260,506,802, and the highest HSDT earnings forecast at -$10,993,400,145.

In 2026, HSDT is forecast to generate -$2,717,219,106 in earnings, with the lowest earnings forecast at -$2,610,661,494 and the highest earnings forecast at -$2,797,137,315.

If you're new to stock investing, here's how to buy Helius Medical Technologies stock.

What is HSDT's revenue growth forecast for 2025-2026?

(NASDAQ: HSDT) Helius Medical Technologies's forecast annual revenue growth rate of -59.46% is not forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 4%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 1,432.68%.

Helius Medical Technologies's revenue in 2025 is $941,000.On average, 3 Wall Street analysts forecast HSDT's revenue for 2025 to be $15,755,658, with the lowest HSDT revenue forecast at $15,137,789, and the highest HSDT revenue forecast at $16,219,060.

In 2026, HSDT is forecast to generate $27,593,465 in revenue, with the lowest revenue forecast at $26,511,369 and the highest revenue forecast at $28,405,038.

What is HSDT's forecast return on assets (ROA) for 2025-2026?

(NASDAQ: HSDT) forecast ROA is -570.94%, which is lower than the forecast US Medical Devices industry average of 10.09%.

What is HSDT's Earnings Per Share (EPS) forecast for 2025-2026?

(NASDAQ: HSDT) Helius Medical Technologies's current Earnings Per Share (EPS) is -$1,259.62. On average, analysts forecast that HSDT's EPS will be -$258.57 for 2025, with the lowest EPS forecast at -$248.43, and the highest EPS forecast at -$266.18. In 2026, HSDT's EPS is forecast to hit -$65.79 (min: -$63.21, max: -$67.73).

What is HSDT's forecast return on equity (ROE) for 2025-2026?

(NASDAQ: HSDT) forecast ROE is N/A, which is considered weak.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.